James R Whittle

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 4

Top Topics

Cardiac Surgery

Top Venues

Future oncology (London, England)

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Cain Craig Truman Clark, Monique Topp, Mark Rosenthal, Robert Tobler, Saskia Freytag, Sarah A Best, James R Whittle, Katharine J Drummond
A perioperative study of Safusidenib in patients with IDH1 -mutated glioma. Future oncology (London, England) (2024)
Cain Craig Truman Clark, Monique Topp, Mark Rosenthal, Robert Tobler, Saskia Freytag, Sarah A Best, James R Whittle, Katharine J Drummond
A perioperative study of Safusidenib in patients with IDH1 -mutated glioma. Future oncology (London, England) (2024)
Arian Lasocki, Michael E Buckland, Tahlia Molinaro, Jing Xie, James R Whittle, Heng Wei, Frank Gaillard
Correlating MRI features with additional genetic markers and patient survival in histological grade 2-3 IDH-mutant astrocytomas. Neuroradiology (2023)
Delphine Merino, James R Whittle, François Vaillant, Antonin Serrano, Goknur Giner, Ana Leticia Maragno, Maïa Chanrion, Emilie Schneider, Bhupinder Pal, Xiang Li, Grant Dewson, Julius Gräsel, Kevin Liu, Najoua Lalaoui, David Segal, Marco J Herold, David Ching Siang Huang, Aaron T L Lun, Olivier Geneste, Guillaume L Lessene, Jane E Visvader, Geoffrey J Lindeman
Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer. Science translational medicine 9 (401) (2018)